Molecular and cellular mechanisms of allergic disease

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 2 SUPPL., 2001, Pages

  Broide, D H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic inflammation; Eosinophil; IgE; IL 4; IL 5; Mast cell; TH2 cell

Indexed keywords

CHEMOKINE RECEPTOR CCR3; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC DISEASE; B LYMPHOCYTE; BASOPHIL; BRONCHUS HYPERREACTIVITY; CYTOKINE RELEASE; EOSINOPHIL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; T LYMPHOCYTE;

EID: 0034872296     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.116436     Document Type: Article

References (55)

1. Pathophysiology of the inflammatory response
2. Molecular basis of allergic diseases
3. Pathophysiology of allergic inflammation
4. Concepts of allergy and hypersensitivity
5. Principles of genetics
6. Epidemiology of allergic diseases
7. Epidemiology of asthma: The year in review
8. Molecular modulation of allergic responses
9. Do genetics play a role in the pathogenesis of asthma?
10. Signaling through the high-affinity IgE receptor Fc epsilon RI
11. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
12. Biology of basophils
13. The low-affinity receptor for IgE
14. The low-affinity IgE receptor (CD23) participates in B cell activation
15. IgE in asthma and atopy: Cellular and molecular connections
16. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE
17. CD23/IgE-medicated regulation of the specific antibody response in vivo
18. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions
19. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE infusions is reversible in vitro and in vivo
20. The expression of murine B cell CD23, in vivo, is regulated by its ligand, IgE
21. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
22. In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody
23. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice
24. Restoration of the antibody response to IgE/antigen complexes in CD23-deficient mice by CD23+ spleen or bone marrow cells
25. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
26. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
27. Treatment of allergic asthma with monoclonal anti-IgE antibody
28. Molecular mechanism of IgE regulation
29. Interleukin-13: Central mediator of allergic asthma
30. Requirement for IL-13 independently of IL-4 in experimental asthma
31. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
32. Biology of eosinophils
33. Mechanisms of eosinophil-associated inflammation
34. Eosinophils express interluekin-5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics
35. Interleukin-5 deficiency abolishes eosinophilia, airway hyperreactivity and lung damage in a mouse asthma model
36. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
37. The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity
38. Human interluekin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF
39. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase
40. Eosinophilia
41. Alpha 4 beta 1, integrin and L-selectin mediate eosinophil rolling at physiological shear rates in vivo
42. E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo
43. Granulocyte-macrophage colony-stimulating factor regulates the functional adhesive state of very late antigen-4 expressed by eosinophils
44. Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-1-deficient mice
45. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent
46. Comparison of human eosinophil and neutrophil ligands for P-selectin: Ligands for P-selectin differ from those from E-selectin
47. Alpha4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep
48. Blockade of CD49d (alpha-4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
49. Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular epithelium
50. Inhibition of eosinophilic inflammation in allergen challenged TNF receptor p55/p75- and TNF receptor p55-deficient mice
51. Allergen-induced airway inflammation and bronchial responsiveness in wild type and IL-4 deficient mice
52. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
53. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
54. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3
55. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice